Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?

Detalles Bibliográficos
Autores principales: Zhao, Li-Min, Zhang, Miao, Zhan, Ze-Lin, Qiu, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131654/
https://www.ncbi.nlm.nih.gov/pubmed/34026878
http://dx.doi.org/10.3389/fcvm.2021.679124
_version_ 1783694745701187584
author Zhao, Li-Min
Zhang, Miao
Zhan, Ze-Lin
Qiu, Mei
author_facet Zhao, Li-Min
Zhang, Miao
Zhan, Ze-Lin
Qiu, Mei
author_sort Zhao, Li-Min
collection PubMed
description
format Online
Article
Text
id pubmed-8131654
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81316542021-05-20 Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes? Zhao, Li-Min Zhang, Miao Zhan, Ze-Lin Qiu, Mei Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2021-05-05 /pmc/articles/PMC8131654/ /pubmed/34026878 http://dx.doi.org/10.3389/fcvm.2021.679124 Text en Copyright © 2021 Zhao, Zhang, Zhan and Qiu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Zhao, Li-Min
Zhang, Miao
Zhan, Ze-Lin
Qiu, Mei
Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
title Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
title_full Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
title_fullStr Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
title_full_unstemmed Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
title_short Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
title_sort does combination therapy with sglt2 inhibitors and renin–angiotensin system blockers lead to greater reduction in cardiorenal events among patients with type 2 diabetes?
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131654/
https://www.ncbi.nlm.nih.gov/pubmed/34026878
http://dx.doi.org/10.3389/fcvm.2021.679124
work_keys_str_mv AT zhaolimin doescombinationtherapywithsglt2inhibitorsandreninangiotensinsystemblockersleadtogreaterreductionincardiorenaleventsamongpatientswithtype2diabetes
AT zhangmiao doescombinationtherapywithsglt2inhibitorsandreninangiotensinsystemblockersleadtogreaterreductionincardiorenaleventsamongpatientswithtype2diabetes
AT zhanzelin doescombinationtherapywithsglt2inhibitorsandreninangiotensinsystemblockersleadtogreaterreductionincardiorenaleventsamongpatientswithtype2diabetes
AT qiumei doescombinationtherapywithsglt2inhibitorsandreninangiotensinsystemblockersleadtogreaterreductionincardiorenaleventsamongpatientswithtype2diabetes

Ejemplares similares